HWEL
Healthwell Acquisition Corp. I [HWEL] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HWEL Stock Summary
In the News
HWEL Financial details
Company Rating
Buy
Market Cap
327.34M
Income
2.5M
Revenue
0
Book val./share
7.72
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Dec 2022
P/E
37.12
Forward P/E
-
PEG
-9.82
P/S
-
P/B
1.35
P/C
-
P/FCF
-240.47
Quick Ratio
0.03
Current Ratio
0.25
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
0.17
EPS next Y
-
EPS next Q
-
EPS this Y
64.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-432.5%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
7.4%
Inst Trans
0.1%
ROA
3%
ROE
4%
ROC
-0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.14-11.885
52W High
-4.77%
52W Low
+16.39%
RSI
58
Rel Volume
0.03
Avg Volume
37.55K
Volume
1.11K
Perf Week
0.05%
Perf Month
1.7%
Perf Quarter
-
Perf Half Y
1.11%
-
-
-
-
Beta
0.049414
-
-
Volatility
0%, 0.05%
Prev Close
0.05%
Price
10.475
Change
0.05%
HWEL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | |
| Net income per share | 0.28 | 0.46 | |
| Operating cash flow per share | -0.08 | -0.04 | |
| Free cash flow per share | -0.08 | -0.04 | |
| Cash per share | 43.45 | 0.01 | |
| Book value per share | 13.37K | 9.68 | |
| Tangible book value per share | 13.37K | 9.68 | |
| Share holders equity per share | 13.37K | 9.68 | |
| Interest debt per share | -303.08 | -0.55 | |
| Market cap | 167.08K | 247.75M | |
| Enterprise value | -582.17K | 247.61M | |
| P/E ratio | 34.1 | 21.71 | |
| Price to sales ratio | 0 | 0 | |
| POCF ratio | -126.27 | -263.04 | |
| PFCF ratio | -126.27 | -263.04 | |
| P/B Ratio | 0 | 1.02 | |
| PTB ratio | 0 | 1.02 | |
| EV to sales | 0 | 0 | |
| Enterprise value over EBITDA | -102.11 | -16.06 | |
| EV to operating cash flow | 439.98 | -262.89 | |
| EV to free cash flow | 439.98 | -262.89 | |
| Earnings yield | 0.03 | 0.05 | |
| Free cash flow yield | -0.01 | 0 | |
| Debt to equity | 0 | 0 | |
| Debt to assets | 0 | 0 | |
| Net debt to EBITDA | -131.42 | 0.01 | |
| Current ratio | 4.46 | 0.5 | |
| Interest coverage | 0 | 0.12 | |
| Income quality | -0.27 | -0.08 | |
| Dividend Yield | 0 | 0 | |
| Payout ratio | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | |
| Capex to revenue | 0 | 0 | |
| Capex to depreciation | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | |
| Graham number | 292.38 | 9.97 | |
| ROIC | 0 | -0.01 | |
| Return on tangible assets | 0 | 0.04 | |
| Graham Net | -1.17K | -0.48 | |
| Working capital | 961.08K | -460.33K | |
| Tangible asset value | 230.58M | 241.99M | |
| Net current asset value | -19.72M | -11.68M | |
| Invested capital | 0 | 0 | |
| Average receivables | 0 | 0 | |
| Average payables | 0 | 8.79K | |
| Average inventory | 0 | 0 | |
| Days sales outstanding | 0 | 0 | |
| Days payables outstanding | 0 | 1.31 | |
| Days of inventory on hand | 0 | 0 | |
| Receivables turnover | 0 | 0 | |
| Payables turnover | 0 | 279.12 | |
| Inventory turnover | 0 | 0 | |
| ROE | 0 | 0.05 | |
| Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0.16 | -0.01 | 0.14 | 0.01 | -0.04 | |
| Operating cash flow per share | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | |
| Free cash flow per share | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | |
| Cash per share | 0.02 | 0.01 | 0.01 | 0 | 0 | |
| Book value per share | 7.64 | 7.63 | 9.68 | 7.76 | 7.72 | |
| Tangible book value per share | 7.64 | 7.63 | 9.68 | 7.76 | 7.72 | |
| Share holders equity per share | 7.64 | 7.63 | 9.68 | 7.76 | 7.72 | |
| Interest debt per share | -0.08 | -0.02 | -0.3 | 0 | 0.01 | |
| Market cap | 302.5M | 304.69M | 247.75M | 317.03M | 321.25M | |
| Enterprise value | 301.97M | 304.32M | 247.61M | 317.04M | 321.48M | |
| P/E ratio | 14.91 | -307.59 | 17.13 | 210.76 | -64.47 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -1.59K | -1.35K | -1.06K | -446.75 | -787.5 | |
| PFCF ratio | -1.59K | -1.35K | -1.06K | -446.75 | -787.5 | |
| P/B Ratio | 1.27 | 1.28 | 1.02 | 1.31 | 1.33 | |
| PTB ratio | 1.27 | 1.28 | 1.02 | 1.31 | 1.33 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -92.29 | -244.36 | -51.94 | -745.02 | -258.25 | |
| EV to operating cash flow | -1.58K | -1.34K | -1.06K | -446.76 | -788.07 | |
| EV to free cash flow | -1.58K | -1.34K | -1.06K | -446.76 | -788.07 | |
| Earnings yield | 0.02 | 0 | 0.01 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0.16 | 0.3 | 0.03 | -0.02 | -0.18 | |
| Current ratio | 3.76 | 1.3 | 0.5 | 0.25 | 0.06 | |
| Interest coverage | 0.13 | 0.88 | 0.04 | 853.1 | 0 | |
| Income quality | -0.07 | 0.91 | -0.06 | -1.89 | 0.33 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 5.28 | 1.17 | 5.61 | 1.45 | 2.63 | |
| ROIC | 0 | 0.02 | 0 | 0 | -0.01 | |
| Return on tangible assets | 0.02 | 0 | 0.01 | 0 | 0 | |
| Graham Net | -0.39 | -0.43 | -0.48 | -0.44 | -0.57 | |
| Working capital | 768.93K | 187.48K | -460.33K | -846.27K | -2.51M | |
| Tangible asset value | 238.62M | 238.38M | 241.99M | 242.39M | 241.25M | |
| Net current asset value | -11.82M | -12.97M | -11.68M | -13.44M | -17.65M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 46.11K | 39.7K | 39.56K | 68.86K | 243.77K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 1.83 | 12.01 | 0.32 | 31.81 | 26.73 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 49.06 | 7.49 | 279.12 | 2.83 | 3.37 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.02 | 0 | 0.01 | 0 | -0.01 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
HWEL Frequently Asked Questions
What is Healthwell Acquisition Corp. I stock symbol ?
Healthwell Acquisition Corp. I is a US stock , located in Winnetka of Il and trading under the symbol HWEL
What is Healthwell Acquisition Corp. I stock quote today ?
Healthwell Acquisition Corp. I stock price is $10.475 today.
Is Healthwell Acquisition Corp. I stock public?
Yes, Healthwell Acquisition Corp. I is a publicly traded company.
Company Profile
- Volume Average 37.55K
- Market Capitalization 327.34M
- CEO Ms. Alyssa J. Rapp
- Headquarters Winnetka,IL,US
- IPO Date 2021-09-23
-
Website
https://www.healthwellspac.com 
Healthwell Acquisition Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire technology-enabled companies in the healthcare industry. The company was incorporated in 2021 and is based in Winnetka, Illinois.
